Abbott Laboratories (ABT)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	6,478,000	6,002,000	6,125,000	6,959,000	8,362,000	9,436,000	10,212,000	9,228,000	8,425,000	8,479,000	7,428,000	6,708,000	5,357,000	4,314,000	4,017,000	4,551,000	4,532,000	4,308,000	4,105,000	3,781,000
Revenue (ttm)	US$ in thousands	39,431,000	39,324,000	39,587,000	40,914,000	43,093,000	44,485,000	45,026,000	43,990,000	42,541,000	41,768,000	39,700,000	36,806,000	34,070,000	31,814,000	30,993,000	31,613,000	31,389,000	30,840,000	30,313,000	30,061,000
Operating profit margin		16.43%	15.26%	15.47%	17.01%	19.40%	21.21%	22.68%	20.98%	19.80%	20.30%	18.71%	18.23%	15.72%	13.56%	12.96%	14.40%	14.44%	13.97%	13.54%	12.58%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $6,478,000K ÷ $39,431,000K
= 16.43%

Abbott Laboratories' operating profit margin has shown a declining trend over the past four quarters, decreasing from a high of 22.42% in Q2 2022 to 16.15% in Q4 2023. This downward trend indicates that the company's profitability from its core operations has been weakening. Factors contributing to this decline could include increased operating expenses, lower revenues, or inefficiencies in cost management. It is important for Abbott Laboratories to closely monitor and address the factors impacting its operating profit margin to ensure sustained profitability and financial performance in the future.